We serve Chemical Name:5-Methyl-1,2-oxazole-3-carbonitrile CAS:57351-99-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-Methyl-1,2-oxazole-3-carbonitrile
CAS.NO:57351-99-2
Synonyms:3-Cyano-5-methylisoxazole;5-Methyl-isoxazole-3-carbonitrile;5-Methylisoxazol-3-carbonitril;3-Isoxazolecarbonitrile,5-methyl;5-METHYL-3-ISOXAZOLECARBONITRILE
Molecular Formula:C5H4N2O
Molecular Weight:108.09800
HS Code:3505100000
Physical and Chemical Properties:
Melting point:N/A
Boiling point:249.4ºC at 760mmHg
Density:1.18g/cm3
Index of Refraction:1.488
PSA:49.82000
Exact Mass:108.03200
LogP:0.85468
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-Cyano-5-methylisoxazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-METHYL-3-ISOXAZOLECARBONITRILE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Methyl-isoxazole-3-carbonitrile Use and application,3-Isoxazolecarbonitrile,5-methyl technical grade,usp/ep/jp grade.
Related News: With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout. 5-Methyl-1,2-oxazole-3-carbonitrile manufacturer A week after the memo was released to employees, Reuters reported that the Justice Department had launched a criminal investigation focused on the Branchburg plant. That same day, May 27, Lilly reported to the U.S. Securities and Exchange Commission that it had received a subpoena from the department seeking documents related to the factory. 5-Methyl-1,2-oxazole-3-carbonitrile supplier The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries. 5-Methyl-1,2-oxazole-3-carbonitrile vendor The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data. 5-Methyl-1,2-oxazole-3-carbonitrile factory With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout.
